A pilot study on the impact of congenital thrombophilia in COVID-19.
作者信息
de la Morena-Barrio Maria Eugenia, Bravo-Pérez Carlos, de la Morena-Barrio Belen, Orlando Christelle, Cifuentes Rosa, Padilla Jose, Miñano Antonia, Herrero Sonia, Marcellini Shally, Revilla Nuria, Bernal Enrique, Gómez-Verdú Jose Miguel, Jochmans Kristin, Herranz María Teresa, Vicente Vicente, Corral Javier, Lozano María Luisa
机构信息
Servicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Department of Haematology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
出版信息
Eur J Clin Invest. 2021 May;51(5):e13546. doi: 10.1111/eci.13546. Epub 2021 Mar 25.
Abstract
摘要
相似文献
1
A pilot study on the impact of congenital thrombophilia in COVID-19.一项关于先天性血栓形成倾向对新型冠状病毒肺炎影响的初步研究。
Eur J Clin Invest. 2021 May;51(5):e13546. doi: 10.1111/eci.13546. Epub 2021 Mar 25.
2
Deficiencies of proteins C, S and antithrombin and factor V Leiden and the risk of ischemic strokes.蛋白C、蛋白S、抗凝血酶缺乏以及因子V莱顿突变与缺血性卒中风险
J Med Life. 2010 Jul-Sep;3(3):235-8.
3
The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms.遗传性血栓形成倾向在韩国无诱因静脉血栓栓塞症患者中的流行率和临床表现。
PLoS One. 2017 Oct 17;12(10):e0185785. doi: 10.1371/journal.pone.0185785. eCollection 2017.
4
Deficiencies of natural anticoagulants, protein C, protein S, and antithrombin.天然抗凝剂、蛋白C、蛋白S和抗凝血酶缺乏。
Circulation. 2011 Oct 4;124(14):e365-8. doi: 10.1161/CIRCULATIONAHA.111.044412.
5
6
Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.小儿血栓栓塞症中自然抗凝剂缺乏的年龄特异性发病情况及分布
Pediatr Res. 2016 Jan;79(1-1):81-6. doi: 10.1038/pr.2015.180. Epub 2015 Sep 15.
7
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.不同类型遗传性易栓症患者因近端深静脉血栓形成导致有症状肺栓塞的风险有所不同。
Thromb Haemost. 2008 Jun;99(6):1030-4. doi: 10.1160/TH08-02-0069.
8
Hereditary thrombophilia in an unselected cohort of venous thrombosis patients in Singapore.新加坡未选择的静脉血栓栓塞患者队列中的遗传性血栓形成倾向。
J Clin Pathol. 2011 Sep;64(9):814-7. doi: 10.1136/jclinpath-2011-200018. Epub 2011 May 18.
9
Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort.抗凝血酶、蛋白 C 和蛋白 S 缺乏症-对大型患者队列进行遗传分析的实践经验。
Thromb Haemost. 2012 Aug;108(2):247-57. doi: 10.1160/TH11-12-0875. Epub 2012 May 25.
10
[Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].121例静脉或动脉血栓形成患者的抗凝血酶III、蛋白C、蛋白S和因子XII遗传性缺乏症
Srp Arh Celok Lek. 1999 Jan-Feb;127(1-2):21-7.
引用本文的文献
1
Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination.针对 COVID-19 疫苗接种后发生罕见凝血功能障碍的患者，可检测蛋白 S 自身抗体。
Sci Rep. 2024 Oct 18;14(1):24512. doi: 10.1038/s41598-024-75514-x.
2
Thrombophilia genetic mutations and their relation to disease severity among patients with COVID-19.COVID-19 患者血栓形成倾向的基因突变及其与疾病严重程度的关系。
PLoS One. 2024 Mar 20;19(3):e0296668. doi: 10.1371/journal.pone.0296668. eCollection 2024.
3
A Rare Case of Pulmonary Embolism, Deep Vein Thrombosis, Bilateral Avascular Necrosis of the Femoral Head, and Miscarriage following COVID-19 in a Patient with Multiple Genetic Coagulation Factor Deficiency-A Case Report.一名患有多种遗传性凝血因子缺乏症的患者在感染新冠病毒后出现肺栓塞、深静脉血栓形成、双侧股骨头缺血性坏死及流产的罕见病例——病例报告
Life (Basel). 2023 Nov 22;13(12):2240. doi: 10.3390/life13122240.
4
Protein S Deficiency and COVID-19: A Brutal Combination Leading to Acute Submassive Bilateral Pulmonary Embolism.蛋白S缺乏与新型冠状病毒肺炎：导致急性次大面积双侧肺栓塞的致命组合。
Cureus. 2023 Jul 8;15(7):e41560. doi: 10.7759/cureus.41560. eCollection 2023 Jul.
5
Inherited thrombophilia: undetected comorbidity complicating COVID-19 infection.遗传性血栓形成倾向：未被检测到的合并症使新冠病毒感染复杂化。
Am J Blood Res. 2023 Jun 15;13(3):94-103. eCollection 2023.
6
Dermatological Manifestations in COVID-19: A Case Study of SARS-CoV-2 Infection in a Genetic Thrombophilic Patient with Mthfr Mutation.新型冠状病毒肺炎的皮肤表现：一例伴有亚甲基四氢叶酸还原酶（Mthfr）突变的遗传性易栓症患者感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的病例研究
Pathogens. 2023 Mar 10;12(3):438. doi: 10.3390/pathogens12030438.
7
Role of Genetic Thrombophilia Markers in Thrombosis Events in Elderly Patients with COVID-19.遗传血栓形成倾向标志物在老年 COVID-19 患者血栓事件中的作用。
Genes (Basel). 2023 Mar 4;14(3):644. doi: 10.3390/genes14030644.
8
Thrombosis risk assessment in patients with congenital thrombophilia during COVID - 19 infection.COVID-19 感染期间先天性血栓形成患者的血栓形成风险评估。
Thromb Res. 2022 Oct;218:151-156. doi: 10.1016/j.thromres.2022.08.020. Epub 2022 Aug 20.
9
Hereditary Thrombophilia in the Era of COVID-19.新冠疫情时代的遗传性血栓形成倾向
Healthcare (Basel). 2022 May 27;10(6):993. doi: 10.3390/healthcare10060993.
10
Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia?我们是否应该对来自东地中海地区的 COVID-19 患者进行遗传性血栓形成倾向筛查？
Med Hypotheses. 2021 Jul;152:110621. doi: 10.1016/j.mehy.2021.110621. Epub 2021 Jun 4.
本文引用的文献
1
Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency.抗凝血酶 p.Thr147Ala：非洲裔人群中导致遗传性抗凝血酶缺陷的首个创始人突变。
Thromb Haemost. 2021 Feb;121(2):182-191. doi: 10.1055/s-0040-1716531. Epub 2020 Sep 13.
2
Palmar digital vein thrombosis in a patient with COVID-19.一名新冠肺炎患者出现掌侧指静脉血栓形成。
Clin Exp Dermatol. 2021 Jan;46(1):183-184. doi: 10.1111/ced.14442. Epub 2020 Sep 22.
3
Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events?解开新冠病毒感染的血栓形成状态之谜：既往存在的易栓风险特征是否是导致血栓形成事件异质性的原因？
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620952884. doi: 10.1177/1076029620952884.
4
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
5
Incidence and features of thrombosis in children with inherited antithrombin deficiency.遗传性抗凝血酶缺陷儿童的血栓形成发生率及特征。
Haematologica. 2019 Dec;104(12):2512-2518. doi: 10.3324/haematol.2018.210666. Epub 2019 Apr 11.
6
Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.蛋白 S 海勒姆突变杂合性与静脉血栓形成风险相关。
Sci Rep. 2017 Apr 4;7:45507. doi: 10.1038/srep45507.
7
PROS1 genotype phenotype relationships in a large cohort of adults with suspicion of inherited quantitative protein S deficiency.PROS1 基因型表型关系在一大群怀疑遗传性定量蛋白 S 缺乏的成年人中。
Thromb Haemost. 2016 Mar;115(3):570-9. doi: 10.1160/TH15-05-0391. Epub 2015 Oct 15.
8
MutationTaster2: mutation prediction for the deep-sequencing age.MutationTaster2：深度测序时代的突变预测
Nat Methods. 2014 Apr;11(4):361-2. doi: 10.1038/nmeth.2890.
9
Inherited risk factors for venous thromboembolism.遗传性静脉血栓栓塞症风险因素。
Nat Rev Cardiol. 2014 Mar;11(3):140-56. doi: 10.1038/nrcardio.2013.211. Epub 2014 Jan 14.
10
Stress and hemostasis: an update.应激与止血：更新。
Semin Thromb Hemost. 2013 Nov;39(8):902-12. doi: 10.1055/s-0033-1357487. Epub 2013 Oct 10.
Zotero 插件